Lower Extremity Threatened Limb Classification System: Risk stratification based on Wound, Ischemia,

NewsBot · Oct 14, 2013

Members do not see these Ads. Sign Up.
The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: Risk stratification based on Wound, Ischemia, and foot Infection (WIfI)
Joseph L. Mills Sr., MDemail address, Michael S. Conte, MD, David G. Armstrong, DPM, MD, PhD, Frank B. Pomposelli, MD, Andres Schanzer, MD, Anton N. Sidawy, MD, MPH, George Andros, MD, the Society for Vascular Surgery Lower Extremity Guidelines Committee
Journal of Vascular Surgery; Article in Press

Critical limb ischemia, first defined in 1982, was intended to delineate a subgroup of patients with a threatened lower extremity primarily because of chronic ischemia. It was the intent of the original authors that patients with diabetes be excluded or analyzed separately. The Fontaine and Rutherford Systems have been used to classify risk of amputation and likelihood of benefit from revascularization by subcategorizing patients into two groups: ischemic rest pain and tissue loss. Due to demographic shifts over the last 40 years, especially a dramatic rise in the incidence of diabetes mellitus and rapidly expanding techniques of revascularization, it has become increasingly difficult to perform meaningful outcomes analysis for patients with threatened limbs using these existing classification systems. Particularly in patients with diabetes, limb threat is part of a broad disease spectrum. Perfusion is only one determinant of outcome; wound extent and the presence and severity of infection also greatly impact the threat to a limb. Therefore, the Society for Vascular Surgery Lower Extremity Guidelines Committee undertook the task of creating a new classification of the threatened lower extremity that reflects these important considerations. We term this new framework, the Society for Vascular Surgery Lower Extremity Threatened Limb Classification System. Risk stratification is based on three major factors that impact amputation risk and clinical management: Wound, Ischemia, and foot Infection (WIfI). The implementation of this classification system is intended to permit more meaningful analysis of outcomes for various forms of therapy in this challenging, but heterogeneous population.
Click to expand...

Admin2 · Oct 15, 2013

Related Threads:
Other threads tagged with peripheral vascular disease
Care pathway to save the ischaemic diabetic foot
Exercise for intermittent claudication
Stem cells and ischemic foot ulcer
Critical limb ischemia
Revascularization has reduced the need for amputations by 40%
Intermittent claudication in the foot[/UR]
'Paradigm shift' in how physicians treat peripheral artery disease
Can peripheral arterial disease be early screened for in a podiatric setting?
Critical limb ischemia criteria are not applicable to diabetic foot
Risk attitudes to treatment among patients with severe intermittent claudication
The Economic Cost of Peripheral Vascular Disease
Antibiotic Penetration in Lower Extremity Ischemic Tissues
Peripheral Vascular Disease: Diagnosis and Treatment
Peripheral Arterial Perfusion: Is it Adequate for Wound Healing?
Genetic basis of peripheral vascular disease
Vascular Involvement in Diabetic Subjects with Ischemic Foot Ulcer

NewsBot · Mar 21, 2016

Validation of the Wound, Ischemia, foot Infection (WIfI) classification system in nondiabetic patients treated by endovascular means for critical limb ischemia.
Beropoulis E et al
J Vasc Surg. 2016 Mar 16

BACKGROUND:
The Society for Vascular Surgery Lower Extremity Guidelines Committee developed the Wound, Ischemia, foot Infection (WIfI) a classification system to predict the amputation risk in patients with critical limb ischemia (CLI). A number of published studies have already evaluated its prognostic value. However, most of the included patients were diabetic, and the validation was done independent of the revascularization procedure. This single-center study evaluated the prognostic value of WIfI stages in nondiabetic patients treated by endovascular means.
METHODS:
A retrospective analysis was performed of prospectively collected data of nondiabetic patients treated by endovascular means between January 2013 and September 2014. All patients were classified according to their wound status, ischemia index, and extent of foot infection to four classes: very low risk, low risk, moderate risk, and high risk. Comorbidities and vascular lesions for each group were analyzed. The prognostic value of WIfI was analyzed based on the amputation-free survival, overall survival rate, and freedom from amputation at 12 months.
RESULTS:
Data from 302 CLI patients treated in the study period were reviewed. A total of 219 patients (73%) underwent an endovascular intervention, and among them, 126 nondiabetic patients (58%) were enrolled in this study. Most patients were classified as low risk (33%), and the prevalence of very low-risk, moderate-risk, and very high-risk patients was 23%, 23%, and 21%, respectively. The modified Edifoligide for the Prevention of Infrainguinal Vein Graft Failure (PREVENT III) score was statistically significantly higher in the high-risk group (5.2 ? 2.4) than in the very low-risk, low-risk, and moderate-risk groups (4.3 ? 2.5, 3.5 ? 2.3, 4.5 ? 2.2, respectively; P = .048). One major amputation (1%) was performed during the hospital stay in a high-risk patient. Mean follow-up was 14 ? 8 months. The amputation-free survival at 12 months was 87%, 81%, 81%, and 62%, in the very low-risk, low-risk, moderate risk, and very high-risk groups, respectively (P = .106). The difference was statistically significant between the very low-risk and high-risk groups (hazard ratio, 3.4; 95% confidence interval, 1.1-10.3; P = .029). A similar trend was also observed for 1-year survival between the very low-risk and the high-risk groups (87%, 84%, 81%, 65%; P = .166). The amputation rate during the follow-up time was 0%, 2% (n = 6), 3% (n = 5), and 12% (n = 9) for the very low-risk, low-risk, moderate-risk, and very high-risk groups, respectively (P = .033).
CONCLUSIONS:
The WIfI classification system predicted the amputation risk and survival in this highly selected group of nondiabetic CLI patients treated by endovascular means, with a statistically significant difference between very low-risk and high-risk patients already at 1 year.
Click to expand...

NewsBot The Admin that posts the news.

Admin2 Administrator Staff Member

NewsBot The Admin that posts the news.

Lower Extremity Surfing Injuries

Lower extremity arterial stenosis scores (LEASS)

Lower Extremity Injuries Due to Chainsaws

Lower Extremity Hematoma Algorithm

Health service organisation impact on lower extremity amputations

Justin Blake talks with Richard Dubin from the Lower Extremity Review

Incidence of Lower Extremity Injury in the National Football League

Share This Page